Skip to content
Open access

HIST1H4L promotes small cell lung cancer tumorigenesis by regulating the PI3K/Akt pathway and serves as a potential diagnostic biomarker

Sep 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 38 references
Medicine

TL;DR

HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways and correlated with poor patient survival; critically, high HIST1H4L expression correlated with poor patient survival.

Abstract

Objective Despite advances in treatment, small cell lung cancer (SCLC) remains highly aggressive and prone to relapse, leading to poor patient outcomes. Histone HIST1H4L is a key protein that maintains chromatin structure, but its role in SCLC is still unclear. This study aims to define its oncogenic role in SCLC and to determine whether it drives malignant progression by activating the PI3K/AKT signaling pathway. Materials and methods Public datasets were used to integrate HIST1H4L expression with differentially expressed genes. Functional bioinformatics investigations and survival association analyses were then conducted. Additionally, stable HIST1H4L knockdown cell lines were generated. Knockdown efficiency was confirmed at the mRNA and protein levels by qRT-PCR and Western blot (WB). Cell proliferation was measured using CCK-8 and EdU staining. Cell invasion was assessed with Transwell assays. Cellular senescence and apoptosis were evaluated by β-galactosidase staining and flow cytometry, respectively. Finally, WB was used to detect changes in key proteins of the PI3K/AKT signaling pathway after HIST1H4L knockdown. Results HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways. Critically, high HIST1H4L expression correlated with poor patient survival. HIST1H4L knockdown markedly suppressed proliferation, migration, and invasion. It also reduced senescence and apoptosis. HIST1H4L knockdown weakened the activation of the PI3K/AKT signaling pathway. The levels of p-AKT and p-PI3K decreased, while total AKT and PI3K levels remained unchanged. Conclusion HIST1H4L is significantly overexpressed in SCLC and correlates with poor prognosis. It functions as a key oncogenic driver by activating the PI3K/AKT pathway, promoting tumor proliferation and invasion.

Read PDF

Similar papers

Review Open access Sep 2026

PINK1 promotes the progression of lung squamous cell carcinoma through the FAK/AKT/RhoA/vinculin pathway

Lung squamous cell carcinoma (LUSC) is an aggressive malignancy with a poor prognosis. Given the association between mitochondrial dysregulation and LUSC, the aim of the present study was to identify mitochondrial unfolded protein response (UPRmt)-related candidate genes associated with LUSC and to explore their potent...

Xu Li, Yu-Hui Ma · 0 citations
Sep 2026

METTL1/USP48 Axis Stabilizes LCN2 Expression to Promote the Malignant Phenotypes of Cutaneous Squamous Cell Carcinoma

Clinically, these findings identify the METTL1/USP48/LCN2 pathway as a potential therapeutic target for cSCC and elucidated a novel oncogenic axis in cSCC, wherein METTL1 stabilized USP48 mRNA through m7G methylation modification, and USP48 in turn deubiquitinated and stabilized LCN2 protein.

Xiu-Qi Li, Lin Shu, Xiao-Qiang Li et al. · 0 citations
Open access Sep 2026

P4HA3 promotes gastric cancer cell proliferation and invasion via the PI3K/AKT/mTOR signaling pathway and regulates glycolytic metabolic reprogramming.

Experimental data indicated that P4HA3 facilitated GC cell proliferation, migration and invasion, and enhanced glycolytic activity and increased the expression of key glycolysis-related proteins, suggesting that P4HA3 may induce a broader metabolic activation rather than an exclusively glycolytic shift.

Tao Wang, Xiao Xu, C. Jin et al. · 0 citations
Open access Sep 2026

SGPP1 as a tumor suppressor in esophageal squamous cell carcinoma: Potential molecular mechanisms involving UGT1A9/UGT2B28 and clinical prognostic significance

SGPP1 functions as a tumor suppressor gene in ESCC and may inhibit tumor progression by regulating UGT1A9/UGT2B28‑mediated metabolic pathways and serve as a prognostic biomarker and a potential therapeutic target in ESCC.

L. Su, L. Hou, Xue-Tao Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.